Sandy Kildegaard Nielsen

A comparison of physician-rated disease severity and patient reported outcomes in mild to moderately active ulcerative colitis

Chris Poole, Mark P. Connolly, Sandy Kildegaard Nielsen et al. · Journal of Crohn s and Colitis · 2009 · 23 citations · Full text

Pharmacy, Internal Medicine, Gastroenterology +16

Cost–effectiveness analysis comparing degarelix with leuprolide in hormonal therapy for patients with locally advanced prostate cancer

Hind T. Hatoum, E. David Crawford, Sandy Kildegaard Nielsen et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2013 · 21 citations

Pharmacy, Oncology, Pharmacoeconomics +17

Planned change in modern hierarchical organizations: A three-step model

Theresa Adelman-Mullally, Sandy Kildegaard Nielsen, Seon Yoon Chung · Journal of Professional Nursing · 2023 · 14 citations

Management, Organization Studies, Organizational Behavior +13

A cost–utility analysis of degarelix in the treatment of advanced hormone-dependent prostate cancer in the United Kingdom

Dawn Lee, J. Porter, Daniel Gladwell et al. · Journal of Medical Economics · 2014 · 13 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +16

An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trial

Mark P. Connolly, Sandy Kildegaard Nielsen, Craig J. Currie et al. · Journal of Crohn s and Colitis · 2008 · 11 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17